Heart failure must be monitored by your health care provider. The first step is usually to identify and treat any underlying disorders and precipitating factors. This may require a thorough diagnostic work-up, medications, catheter procedures, or surgery. The goals include reducing the heart's workload, controlling excess salt and water retention (swelling, reduced urinary output) and improving heart function. In advanced cases or when the heart failure occurs suddenly (acute heart failure), bed rest or reduced physical activity are recommended to minimize the heart's workload. If salt and fluid intake have been reduced and swelling persists or there are signs of severe systemic (body) or pulmonary (lung) congestion, it may be necessary to use diuretics (water pills). Diuretics include: - Loop diuretics (e.g., furosemide, bumetanide) for moderate symptoms
- Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone, chlorothiazide) for mild symptoms
- Potassium-sparing diuretics (spironolactone, triamterene) to prevent excessive potassium losses
Digoxin may also be given, especially if the heart rhythm is irregular due to atrial fibrillation. Medications to reduce the heart's workload include ACE inhibitors such as captopril and enalapril, and angiotensin receptor blockers such as losartan and candesartan. Vasodilators such as hydralazine and long-acting nitrates are also commonly used. The majority of patients, particularly those with a history of coronary artery disease, may benefit from low doses of beta-blockers. Weight loss may be recommended for overweight patients. Patients should also reduce smoking and excessive alcohol consumption, because these decrease the pumping efficiency of the heart.
If symptoms are very limiting and minimal activity causes difficulty breathing, or if there is no response to the initial treatment, hospitalization may be required. Hospitalized patients may receive oxygen and intravenous medications such as vasodilators and diuretics. The heart's ability to pump blood can be directly increased by medications called inotropic agents. These include dobutamine and milrinone, which are given intravenously. Unstable patients receiving several medications usually need also hemodynamic monitoring with Swan-Ganz catheterization. Severe cases require more drastic measures. For example, excess fluid can be removed through dialysis, and circulatory assistance can be provided by implanted devices such as the intra-aortic balloon pump (IABP) and the left ventricular assist device (LVAD). These devices can be life-saving, but they are not permanent solutions. Patients who become dependent on circulatory support will need a heart transplant.
|